News & Comments

About Exelixis’ Transition

EXELIXIS Exelixis’ (EXEL) shareholders know well how good are the firm’s announced financial results for the second quarter of 2017. They also know well how good is the update presented by the …

An Approval for Celgene and Two Breakthrough Designations for AstraZeneca

CELGENE Good news from Celgene (CELG) announced  that the FDA approved the firm’s targeted drug Idhifa (enasidenib) for adults with relapsed or refractory acute myeloid leukemia (AML) …

Why Eli Lilly Wanted Nektar’s Drug NKTR-358 So Badly. Incyte’s Most Recent News

It took only a few months after the dosing stages of NKTR-358 in in a Phase I trial for Eli Lilly to strike a deal worth $400 million with the ascending firm Nektar (NKTR) related to the drug. Eli …

 

Today’s Highlights

Why Sangamo Rallied

About Our New Section On Saturday, August 19, 2017 We Will Post Our First “The Week in Review” Article. This current week has carried bad news, …

Stocks’ Declines That Offer Real Opportunities for Accumulation at Bargain Prices

AFTER MANY OF THE PROHOST PICKED STOCKS NEARED REACHING THE PROHOST NEAR-TERM TARGETS, recently, external circumstances and exaggerated delaying …

Reasons for Vertex’s & Illumina’s Outperformance

Synopsis Most of the Prohost picked stocks gained momentum and closed higher at the end of the week. Some rallied because that’s what they were …

Amgen Outperformed and Will Continue to Outperform

Amgen’s (AMGN) stock outperformed in the past 6 months for significant reasons and these reasons are still there as we observed listening to the …

Recent Popular Posts:

The STAR of the Week and More

THE WEEK IN REVIEW  Wall Street As we said in yesterday’s article posted under Today’s Highlights, stocks can plummet at any time, regardless of whether they have the best or the worst grades for their financial …

Why Sangamo Rallied

About Our New Section On Saturday, August 19, 2017 We Will Post Our First “The Week in Review” Article. This current week has carried bad news, political hypocrisy and a catastrophic terrorist attack on the people …

Top